Denali Therapeutics Inc. — DEFA14A Filings
8 DEFA14A filings on record
This page lists all DEFA14A filings submitted to the SEC by Denali Therapeutics Inc. (DNLI), sorted by most recent first. Each row links to the full filing on EdgarLookup. Denali Therapeutics Inc. has filed 8 DEFA14A documents with the SEC since 2017. To view all SEC filings by Denali Therapeutics Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEFA14A | DEFA14A | 0001714899-25-000088 | Apr 17, 2025 | — |
| DEFA14A | DEFA14A | 0001714899-24-000111 | Apr 18, 2024 | — |
| DEFA14A | DEFA14A | 0001714899-23-000063 | Apr 18, 2023 | — |
| DEFA14A | DEFA14A | 0001714899-22-000069 | Apr 19, 2022 | — |
| DEFA14A | DEFA14A | 0001714899-21-000043 | Apr 22, 2021 | — |
| DEFA14A | DEFA14A | 0001714899-20-000042 | Apr 22, 2020 | — |
| DEFA14A | DEFA14A | 0001714899-19-000023 | Apr 18, 2019 | — |
| DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001193125-18-134914 | Apr 26, 2018 | — |